دورية أكاديمية

Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

التفاصيل البيبلوغرافية
العنوان: Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
المؤلفون: van Nimwegen, Jolien F, Mossel, Esther, van Zuiden, Greetje S, Wijnsma, Robin F, Delli, Konstantina, Stel, Alja J, van der Vegt, Bert, Haacke, Erlin A, Olie, Lisette, Los, Leonoor I, Verstappen, Gwenny M, Pringle, Sarah A, Spijkervet, Fred K L, Kroese, Frans G M, Vissink, Arjan, Arends, Suzanne, Bootsma, Hendrika *
المصدر: In The Lancet Rheumatology March 2020 2(3):e153-e163
قاعدة البيانات: ScienceDirect
الوصف
تدمد:26659913
DOI:10.1016/S2665-9913(19)30160-2